title: Management of early stage non-small cell lung cancer in high-risk patients.
abstract: The preferred treatment of stage I non-small cell lung cancer (NSCLC) is anatomic resection with systematic mediastinal lymph node evaluation. However, 20% of patients with operable lung cancer are not candidates for this type of resection. Recent advancements in radiology-guided technologies have expanded the treatment options for high-risk patients with early-stage NSCLC. There has simultaneously been resurgence in interest and refinement of indications and techniques for sublobar resection in this population. While these treatments appear to have decreased peri-procedural morbidity and mortality, their oncologic efficacy compared to that of lobectomy remains to be determined.
authors: Department of Cardiothoracic Surgery, NYU School of Medicine, 530 1st Avenue, Suite 9V, New York, NY 10016, USA. jessica.donington@nyumc.org
authors: Jessica S
authors: JS
authors: Donington
authors: Justin D
authors: JD
authors: Blasberg
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D013997:Time Factors